Omniab Inc (OABI)
Omniab stock today
Omniab closed at $5.11 on October 30, 2026, down 2.29% on the day. Over the past year it returned +243.0% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $741 million.
| Period | OABI | S&P 500 (SPY) |
|---|---|---|
| 1 month | +3.0% | -0.9% |
| 3 months | +156.8% | +2.1% |
| Year to date | +176.2% | +11.7% |
| 1 year | +243.0% | +12.4% |
| 3 years | +13.8% | +88.5% |
Key statistics
- Market value
- $741M
- Price / sales
- 19.3
- 52-week range
- $1.36 to $5.28
About Omniab
OmniAb develops antibody-based therapeutics and related biological research services.
Sector: Health Care
More on Omniab
- Financials: revenue, earnings and segmentsRevenue -29% in the year to Dec 2025
- Returns: what $1,000 became$1,000 three years ago is $1,138 today
No forecast, no recommendation. This page describes Omniab Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.